Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer

International patterns and trends in ovarian cancer incidence, overall and by histologic subtype

(2017) S.B. Coburn et al.   INTERNATIONAL JOURNAL OF CANCER

Ovarian cancer stem cells more questions than answers

(2017) Petronella Beatrix Ottevanger   SEMINARS IN CANCER BIOLOGY

Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer

(2017) Zan-Hui Jia et al.   PLoS One

Cancer treatment and survivorship statistics, 2016

(2016) Kimberly D. Miller et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Low oxygen level increases proliferation and metabolic changes in bovine granulosa cells

(2016) Shogo Shiratsuki et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Chemoresistance and targeted therapies in ovarian and endometrial cancers

(2016) Kevin Brasseur et al.   Oncotarget

Acute exposure to apolipoprotein A1 inhibits macrophage chemotaxis in vitro and monocyte recruitment in vivo

(2016) Asif J Iqbal et al.   eLife

The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer

(2015) Seiji Mabuchi et al.   GYNECOLOGIC ONCOLOGY

Apolipoprotein A-I inhibits experimental colitis and colitis-propelled carcinogenesis

(2015) K K Gkouskou et al.   ONCOGENE

FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer

(2015) Qipeng Fan et al.   Oncotarget

A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway

(2015) Azadeh Cheraghchi-Bashi et al.   Oncotarget

APOA1 mRNA Expression in Ovarian Serous Carcinoma Effusions Is a Marker of Longer Survival

(2014) Helene Tuft Stavnes et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Label-Free LC-MSe in Tissue and Serum Reveals Protein Networks Underlying Differences between Benign and Malignant Serous Ovarian Tumors

(2014) Wouter Wegdam et al.   PLoS One

Diverse Mechanisms of AKT Pathway Activation in Human Malignancy

(2013) Mitchell Cheung et al.   CURRENT CANCER DRUG TARGETS

The Cardioprotective Protein Apolipoprotein A1 Promotes Potent Anti-tumorigenic Effects

(2013) Maryam Zamanian-Daryoush et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Biomarker Testing for Ovarian Cancer: Clinical Utility of Multiplex Assays

(2013) Brian M. Nolen et al.   Molecular Diagnosis & Therapy

A new era for quantifying HDL and cardiovascular risk?

(2012) Jay W Heinecke   NATURE MEDICINE

The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer

(2012) Arthur B. McKie et al.   Cancer Discovery

L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways

(2011) Feng Gao et al.   Integrative Biology

D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD

(2011) Ekambaram Ganapathy et al.   INTERNATIONAL JOURNAL OF CANCER

Reactive oxygen species mediate lysophosphatidic acid induced signaling in ovarian cancer cells

(2010) Jerry A. Saunders et al.   FREE RADICAL BIOLOGY AND MEDICINE

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

(2010) F. Su et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Progesterone Receptor-Induced Gene Expression in Primary Mouse Granulosa Cell Cultures1

(2009) Venkataraman Sriraman et al.   BIOLOGY OF REPRODUCTION

The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer

(2009) X B Trinh et al.   BRITISH JOURNAL OF CANCER

Promising molecular targets in ovarian cancer

(2009) Sarah Blagden et al.   CURRENT OPINION IN ONCOLOGY

Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice

(2009) H. Li et al.   MOLECULAR CANCER THERAPEUTICS

The reverse cholesterol transport system as a potential mediator of luteolysis in the primate corpus luteum

(2009) Randy L Bogan et al.   REPRODUCTION

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I

(2008) Brian J. Van Lenten et al.   JOURNAL OF LIPID RESEARCH